Stellantis and Leapmotor Adjust B10 EV Production Plans
Stellantis, in partnership with Leapmotor, has abandoned plans to produce its second electric vehicle (EV) model, the B10, at its Polish facility. The decision follows pressure from the Chinese government, which instructed automakers to halt large investments in EU nations that supported the imposition of tariffs on Chinese EVs.
Shift to New Production Locations
Instead of Poland, the joint venture is now considering Stellantis’ factories in Eisenach, Germany, and Trnava, Slovakia, as potential sites for manufacturing the B10 electric crossover. This shift comes after Poland, a proponent of the EU tariff on Chinese EV imports, was identified as an unfavorable location for investment by the Chinese Ministry of Commerce.
EU Tariff Controversy
Poland, along with nine other EU members, supported the 45% tariff on Chinese EVs, which took effect on October 30. Conversely, Germany and Slovakia, along with several other EU countries, opposed the move. This has led to uncertainties about the B10's production location, with the impact of these geopolitical tensions still unfolding.
Impact of Geopolitical Pressure
The change in production sites may lead to higher production costs in Germany due to higher utility and labor expenses compared to Poland. Despite the shift, Stellantis and Leapmotor remain committed to making the B10 a key model for markets outside China, including Europe.
For further reading, you can check out the following sources:
- Chinese Automakers Reassess Investment in Europe Amid Tariff Dispute
- Stellantis and Leapmotor Adjust EV Plans in Response to EU Tariffs
- EU Members Clash Over Tariffs on Chinese-Made Electric Vehicles


Apple Turns 50: From Garage Startup to AI Crossroads
First Western Ship Transits Strait of Hormuz Since Iran War Began
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 



